Brief: Cumberland Pharmaceuticals Reports 14% Revenue Growth
09/08/2022 22:25
Aug 9 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS 14% REVENUE GROWTH
* Q2 ADJUSTED LOSS PER SHARE $0.01
* QUARTERLY REVENUE $10.3 MILLION
Source text for Eikon: ID:nPn76zjKCa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM